中国病案
中國病案
중국병안
CHINESE MEDICAL RECORD
2013年
5期
72-74
,共3页
弥漫性轴索损伤%S100B%格拉斯哥预后评分
瀰漫性軸索損傷%S100B%格拉斯哥預後評分
미만성축색손상%S100B%격랍사가예후평분
Diffuse axonal injury%S100B%Glasgow outcome scale
目的观察弥漫性轴索损伤患者血清S100B浓度及变化意义及对治疗效果的预测.方法收集2006年1月-2009年12月30例脑外伤弥漫性轴索患者资料,进行回顾性分析.病人入院后6、24、48、72小时分别抽取空腹外周静脉血,酶联免疫吸附法测定血清S -100β蛋白,同时记录其格拉斯哥昏迷评分.分析GCS及血清S100B与病人3个月及2年格拉斯哥预后评分的相关性.结果病人于6、24、48、72小时行血清S100B检测结果分别为549.73±86.65ng/L、412.27±76.22ng/L、215.70±55.75ng/L、110.97±18.01ng/L.组间数据差异显著( P<0.05).GCS预测3个月和2年GOS(GOS=4~5)的以72小时结果最佳( P<0.01),以受试者工作特征曲线计算曲线下面积分别为0.882±0.060,0.932±0.045,而S100B相应72小时血清浓度预测3个月和2年GOS((GOS=1~3))时ROC曲线下面积分别为0.952±0.038,0.949±0.073( P<0.01).结论弥漫性轴索损伤患者严重程度与血清S100B 蛋白含量呈正相关.血清S100B浓度比 GCS预测结果更为准确.对弥漫性轴索损伤患者治疗期间的S100B 蛋白水平进行动态监测,对于评定治疗效果、预后情况是十分必要的.
目的觀察瀰漫性軸索損傷患者血清S100B濃度及變化意義及對治療效果的預測.方法收集2006年1月-2009年12月30例腦外傷瀰漫性軸索患者資料,進行迴顧性分析.病人入院後6、24、48、72小時分彆抽取空腹外週靜脈血,酶聯免疫吸附法測定血清S -100β蛋白,同時記錄其格拉斯哥昏迷評分.分析GCS及血清S100B與病人3箇月及2年格拉斯哥預後評分的相關性.結果病人于6、24、48、72小時行血清S100B檢測結果分彆為549.73±86.65ng/L、412.27±76.22ng/L、215.70±55.75ng/L、110.97±18.01ng/L.組間數據差異顯著( P<0.05).GCS預測3箇月和2年GOS(GOS=4~5)的以72小時結果最佳( P<0.01),以受試者工作特徵麯線計算麯線下麵積分彆為0.882±0.060,0.932±0.045,而S100B相應72小時血清濃度預測3箇月和2年GOS((GOS=1~3))時ROC麯線下麵積分彆為0.952±0.038,0.949±0.073( P<0.01).結論瀰漫性軸索損傷患者嚴重程度與血清S100B 蛋白含量呈正相關.血清S100B濃度比 GCS預測結果更為準確.對瀰漫性軸索損傷患者治療期間的S100B 蛋白水平進行動態鑑測,對于評定治療效果、預後情況是十分必要的.
목적관찰미만성축색손상환자혈청S100B농도급변화의의급대치료효과적예측.방법수집2006년1월-2009년12월30례뇌외상미만성축색환자자료,진행회고성분석.병인입원후6、24、48、72소시분별추취공복외주정맥혈,매련면역흡부법측정혈청S -100β단백,동시기록기격랍사가혼미평분.분석GCS급혈청S100B여병인3개월급2년격랍사가예후평분적상관성.결과병인우6、24、48、72소시행혈청S100B검측결과분별위549.73±86.65ng/L、412.27±76.22ng/L、215.70±55.75ng/L、110.97±18.01ng/L.조간수거차이현저( P<0.05).GCS예측3개월화2년GOS(GOS=4~5)적이72소시결과최가( P<0.01),이수시자공작특정곡선계산곡선하면적분별위0.882±0.060,0.932±0.045,이S100B상응72소시혈청농도예측3개월화2년GOS((GOS=1~3))시ROC곡선하면적분별위0.952±0.038,0.949±0.073( P<0.01).결론미만성축색손상환자엄중정도여혈청S100B 단백함량정정상관.혈청S100B농도비 GCS예측결과경위준학.대미만성축색손상환자치료기간적S100B 단백수평진행동태감측,대우평정치료효과、예후정황시십분필요적.
@@@@Objective To observe the changes of levels of S100B concentrations in patients with diffuse axonal injury (DAI ) and its prediction of patients’outcome .Methods Data of thirty patients from Jan 2006 to Dec 2009 with diffuse axonal injury were analyzed respectively .Al patients’ serum levels of S100B concentrations were measured at 6、24、48、72 hours after admission by ELISA .Recording the GOS score .Analyzing correlation between GCS and serum S100B of patients for 3 months and 2 year with GOS .Results The serum levels of S100B at 6、24、48、72 hours were 549 .73 ± 86 .65ng/L ,412 .27 ± 76 .22ng/L ,215 .70 ± 55 .75ng/L ,110 .97 ± 18 .01ng/L respectively .The differences between groups was significant ( P<0 .05) .The prognostic value of GCS at 72 hours was significantly higher with favorable outcome (GOS=4~5) versus unfavorable outcome (GOS=1~3) ( P<0 .01) ,area under the ROC curve of GCS at 72 hours for favorable outcome 3 months and 2 years after injury were 0 .882 ± 0 .060 ,0 .932 ± 0 .045 respectively ,w hile the prognostic value of S100B at 72 hours was significantly higher with unfavorable outcome (GOS = 1 ~ 3 ) versus favorable outcome (GOS=4~5) ( P< 0 .01) ,area under the ROC curve of S100B at 72 hours for unfavorable outcome 3 months and 2 years after injury were 0 .952 ± 0 .038 ,0 .949 ± 0 .073 respectively .Conclusion The level of serum S100B concentration was positively correlative with the severity of DAI .The serum levels of S100B versus GCS has a higher ability to predict GOS .It is necessary to monitor frequently the serum levels of S 100B during treatment of DAI for evaluation of therapeutic regimen and prognosis .